Search Results
15 items found for "Yu Chen"
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
October 2022 β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling advanced NanoLuc/FlAsH-based biosensors reveals distinct conformational signatures of β-arrestin1 and 2 when
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu
- Regulators of G-protein signaling: essential players in GPCR signaling
and subsequent activation of the G-protein heterotrimeric complex (α, β, and γ); it is at this point when Liu-Chen, and J.R. J Biol Chem, 2009. 284(27): p. 18357-67. https://pubmed.ncbi.nlm.nih.gov/19416973/ 5.
- VAMP2: a crucial player in the delivery of MOR to the synapse
Through developing a high-resolution method, Hao Chen et al. directly visualized the fusion of vesicles Chen, X. Zhang, and L. Ma. 2008.
- Targeting Intracellular Allosteric Sites in GPCRs
this has the potential to enhance GPCR subtype-selectivity, it also presents a significant challenge when modulators (NAMs), that fully or partially dampen the receptor's functional response to the ligand (Wold, Chen selectivity, which can arise from greater sequence variation in allosteric sites among receptor subtypes when This is particularly important when dealing with receptor subtypes that exhibit significant similarity substantial doses of allosteric modulators with a diminished risk of target-related toxicity (Wold, Chen
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
J Biol Chem, 2018. 293(19): p. 7466-7473. 8. Nat Chem Biol, 2020. 16(8): p. 841-849. 10. J Biol Chem, 2007. 282(14): p. 10576-84. 13.
- Decoding β-Arrestins: from Structure to function
activation initiates conformational changes, exposing an intracellular cavity (Kang, Y. et al. 2015, Chen F et al. 2021, Chen, H. et al. 2022).
- 📰 GPCR Weekly News, October 16 to 22, 2023
Norton Cheng and Dr.
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
was the most common method for predicting G protein-coupled receptor (GPCR) structures, especially when antipsychotic-like effects in rodent models, reinforcing the value of AlphaFold in drug discovery, especially when Nat Chem Biol 7 , 769-778 (2011). https://doi.org/10.1038/nchembio.662 Diaz-Holguin, A.
- Overview of adhesion GPCRs self-activation
When I started studying aGPCRs, the structural conformation of the GAIN domain of ADGRL1/Lphn1 and ADGRB3 of human ADGRL3-G13, this paper reports that the stalk peptide of ADGRL3 adopts a hook conformation when Furthermore, when an alignment analysis of the Stalk peptide of the aGPCR family was performed highlighted ., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen
- 📰 GPCR Weekly News, April 22 to 28, 2024
Dysfunction of the adhesion GPCR latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity Norton Cheng
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
When it comes to signal transduction, cellular context matters. Pharmaceuticals (Basel, Switzerland), 14(5), 439. https://doi.org/10.3390/ph14050439 Chen, K.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Chem Rev, 2017. 117 (1): p. 111-138.
- Structural landscape of the Chemokine Receptor system
When comparing the CKRs structures complexes, the disulfide bridges formed between the N-loop and the agonist (maraviroc) (Tan, Zhu et al. 2013, Zheng, Han et al. 2017, Isaikina, Tsai et al. 2021, Zhang, Chen CCL15L (residues 26-92) and CCL15M (residues 27-92), while the third structure lacks a ligand (Shao, Shen conformational change of Y2917.43 tilted toward TM2, a model supported by mutagenesis experiments (Shao, Shen
- 📰 GPCR Weekly News, January 1 to 7, 2024
Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer Rhythm Pharmaceuticals and LG Chem